Skip to content

Clinical trials

Cerebrovascular Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebrovascular Disorders Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20121
20141
20172
20183
20211
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neuroscience Trials Australia4
University of Melbourne2
4D Molecular Therapeutics1
Bayer1
Cogentus Pharmaceuticals1
Eli Lilly and Company1
Garvan Institute of Medical Research1
Monash University1
Population Health Research Institute1
Region Skane1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebrovascular Disorders16
Stroke10
Cardiovascular Diseases9
Central Nervous System Diseases8
Brain Diseases7
Vascular Diseases7
Ischemic Stroke6
Nervous System Diseases6
Cerebral Hemorrhage3
Acute Coronary Syndrome2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.